T. Rowe Price Investment Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-397,962
| Closed | -$4.5M | – | 744 |
|
|
2025
Q1 | $4.5M | Sell |
397,962
-2,285
| -0.6% | -$25.8K | ﹤0.01% | 590 |
|
|
2024
Q4 | $4.2M | Buy |
400,247
+2,598
| +0.7% | +$27.3K | ﹤0.01% | 580 |
|
|
2024
Q3 | $4.16M | Sell |
397,649
-2,351
| -0.6% | -$24.6K | ﹤0.01% | 570 |
|
|
2024
Q2 | $4.09M | Hold |
400,000
| – | – | ﹤0.01% | 576 |
|
|
2024
Q1 | $4.14M | Buy |
+400,000
| New | +$4.14M | ﹤0.01% | 574 |
|